The 15-membered caffrane ring of the natural product group of combreta
statins D is synthesized in high yield with suitably functionalized sa
turated seco acids. The key step is a Mitsunobu-type macrolactonizatio
n. A common synthon is used for the construction of both combretastati
ns. The synthesis of combretastatin D-2 is completed by the use of Sam
muelson's dehydroxylation protocol, The asymmetric epoxide of combreta
statin D-1 is constructed in two separate operations: one asymmetric c
enter is fixed at an early stage of the synthetic route by Sharpless A
D of a trans-styrene derivative, inducing the intramolecular formation
of the asymmetric epoxide at the final stages. The synthesis of the t
itle compounds is accomplished in high overall yields (37% for D-1 and
41% for D-2, 9 steps in both cases). X-ray crystallographic analysis
of the (S)-(+) acetylmandelic ester of (-)-combretastatin D-1 verified
its revised structure.